Alexandria Real Estate Equities
ARE
#2258
Rank
NZ$13.88 B
Marketcap
NZ$80.11
Share price
-4.10%
Change (1 day)
-50.62%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -NZ$1.71 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are NZ$2.94 Billion. a decrease over its 2024 earnings that were of NZ$1.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$1.73 Billion-242.13%
2024 NZ$1.21 B96.11%
2023 NZ$0.61 B-53.56%
2022 NZ$1.33 B-3.96%
2021 NZ$1.38 B-20.26%
2020 NZ$1.73 B72.88%
2019 NZ$1.00 B3.11%
2018 NZ$0.97 B73.54%
2017 NZ$0.56 B464.88%
2016 NZ$99.44 M-77.32%
2015 NZ$0.43 B36.31%
2014 NZ$0.32 B-10.81%
2013 NZ$0.36 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.73 B-1,129.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$44.77 B-2,699.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.61 B-1,006.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.04 B-1,089.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.06 B-219.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.23 B-1,042.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.00 B-158.16%๐Ÿ‡บ๐Ÿ‡ธ USA